No se publicó un resumen junto con este documento; las guías de sociedades, las vías de consenso y las declaraciones científicas suelen difundirse sin él. Consulte los Puntos Clave y el PDF enlazado para ver el contenido completo.
“Not every patient is a good candidate for every drug; these guidelines can help physicians decide who best fits which treatment. This document details the benefits and risks of these new therapies so that patients at high risk can be directed toward alternative therapies.”
Yancy et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: